V Orlando
Overview
Explore the profile of V Orlando including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
2988
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alesi V, Genovese S, Roberti M, Sallicandro E, Di Tommaso S, Loddo S, et al.
Hum Genomics
. 2024 Mar;
18(1):29.
PMID: 38520002
Chromosomal structural rearrangements consist of anomalies in genomic architecture that may or may not be associated with genetic material gain and loss. Evaluating the precise breakpoint is crucial from a...
2.
Perrella A, Trama U, Bernardi F, Russo G, Monastra L, Fragranza F, et al.
Eur Rev Med Pharmacol Sci
. 2020 May;
24(9):5183-5185.
PMID: 32432786
No abstract available.
3.
Lanzillo R, Moccia M, Palladino R, Signoriello E, Carotenuto A, Maniscalco G, et al.
Mult Scler Relat Disord
. 2019 Dec;
38:101871.
PMID: 31786463
Background: Dimethyl-fumarate (DMF) was effective and safe in relapsing-remitting multiple sclerosis (MS) in randomized clinical trials. We aimed to evaluate the efficacy and safety of DMF and factors related to...
4.
Cattaneo C, Di Blasi R, Skert C, Candoni A, Martino B, Di Renzo N, et al.
Ann Hematol
. 2018 Apr;
97(9):1717-1726.
PMID: 29705860
Infections by multidrug-resistant (MDR) bacteria are a worrisome phenomenon in hematological patients. Data on the incidence of MDR colonization and related bloodstream infections (BSIs) in haematological patients are scarce. A...
5.
Meraviglia S, Lo Presti E, Tosolini M, La Mendola C, Orlando V, Todaro M, et al.
Oncoimmunology
. 2017 Nov;
6(10):e1347742.
PMID: 29123962
γδ T cells usually infiltrate many different types of cancer, but it is unclear whether they inhibit or promote tumor progression. Moreover, properties of tumor-infiltrating γδ T cells and those...
6.
Arcopinto M, Cataldi M, De Luca V, Orlando V, Simeone G, DAssante R, et al.
Transl Med UniSa
. 2017 Aug;
16:24-29.
PMID: 28775966
Although there is evidence of a growing awareness of the problem, no official policy statements or regulatory guidelines on polypharmacy have been released up to date by Italian Health Authorities....
7.
Farina G, Menditto E, Manna S, Pagliaro C, Troncone C, Putignano D, et al.
Value Health
. 2016 May;
17(7):A464-5.
PMID: 27201311
No abstract available.
8.
Orlando V, Bruzzese D, Putignano D, Guerriero F, Tettamanti A, Menditto E
Value Health
. 2016 May;
17(7):A423.
PMID: 27201079
No abstract available.
9.
Putignano D, Fiorentino D, Guerriero F, Monetti V, Orlando V, Menditto E
Value Health
. 2016 May;
17(7):A415.
PMID: 27201034
No abstract available.
10.
Orlando V, Guerriero F, Monetti V, Putignano D, Moretti A, Iolascon G, et al.
Value Health
. 2016 May;
17(7):A384.
PMID: 27200866
No abstract available.